SCOPE Europe (Summit for Clinical Trials Operations Executives)
- Start Date:
20 Apr 2022
- End Date:
21 Apr 2022
Track: Feasibility, Site Selection and Study Activation
Simulating Patient Participation Rates to Inform Early Clinical Study Design
Speaker: Kevin Marsh, PhD, Executive Director, Patient-Centered Research, Evidera | PPD, part of Thermo Fisher Scientific
Wednesday 20 April 2022
Evidera has developed a unique data asset of patient participation decisions to allow early clinical trial design decisions to be informed by quantitative estimates of participate rates. This presentation will report on the data asset and demonstrate its application to study design, including its use to simulate how participation rates vary with alternative study designs, such as decentralization strategies, type of data collection, and tactics to improve the representativeness of study samples.
Discover how PPD is committed to operational excellence across drug development.
Explore how PPD’s expertise and experience to extract insight from real-world data can help your organization.